Status:
RECRUITING
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to l...
Eligibility Criteria
Inclusion
- Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
- Patients can participate in any additional research studies during the patients' participation within this protocol.
Exclusion
- Patients who do not have presumed bladder cancer will not be eligible
Key Trial Info
Start Date :
November 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2035
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03413982
Start Date
November 2 2017
End Date
January 1 2035
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160